v3.25.2
Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Mar. 31, 2024
Current assets:    
Cash and cash equivalents $ 9,136 $ 8,608
Other current assets 473 783
Total current assets 9,609 9,391
Long-term assets:    
Fixed assets, net 21 16
Deferred offering costs 176 0
Total long-term assets 197 16
Total Assets 9,806 9,407
Current liabilities:    
Accounts payable 676 492
Accrued expenses 1,031 285
Total current liabilities 1,707 777
Long-term liabilities:    
Long term debt - convertible notes, net of unamortized debt discount 0 1,002
Total long-term liabilities 0 1,002
Total Liabilities 1,707 1,779
Commitments and contingencies (Note 5)
Stockholders' equity:    
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively. 0 0
Common stock, $0.001 par value, 500,000,000 shares authorized, 2,497,033 and 942,575 shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively. 2 1
Additional paid-in capital 58,476 46,596
Accumulated deficit (50,379) (38,969)
Total Stockholders' Equity 8,099 7,628
Total Liabilities and Stockholders' Equity $ 9,806 $ 9,407